Company intelligence / Profile preview
PolyAdvant
Shenzhen, Guangdong, Chinapolyadvant.com ↗
- Ownership
- Private
- Employees
- ~6
- Development stage
- Other
01
Overview
PolyAdvant is a pioneering biotechnology company focused on developing radiotherapy-activated therapeutics for precision oncology. Founded in 2021 and based on research published in Nature Chemistry, the company's platform utilizes ionizing radiation from standard radiotherapy as an external chemical trigger to selectively activate anticancer prodrugs directly within the tumor microenvironment. This approach aims to combine the spatial precision of radiotherapy with targeted drug delivery, thereby enhancing therapeutic efficacy while minimizing systemic side effects. PolyAdvant's pipeline includes two lead pre-clinical programs: XP-102, a GLUT1-targeted small-molecule conjugate, and XPADC-106, a radiotherapy-activated antibody-drug conjugate (ADC) targeting EGFR.
- Therapeutic areas
- Oncology
- Modalities
- Small moleculeAntibody-drug conjugateBiologic
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on PolyAdvant.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PolyAdvant.